Goldman Sachs’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Sell |
|
|||||
|
2025
Q1 | $1.85M | Buy |
|
|||||
|
2024
Q4 | $908K | Buy |
|
|||||
|
2024
Q3 | $529K | Buy |
|
|||||
|
2024
Q2 | $206K | Sell |
|
|||||
|
2024
Q1 | $669K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $16K | Sell |
|
|||||
|
2022
Q2 | $540K | Sell |
|
|||||
|
2022
Q1 | $874K | Sell |
|
|||||
|
2021
Q4 | $1.61M | Buy |
|
|||||
|
2021
Q3 | $2.21M | Sell |
|
|||||
|
2021
Q2 | $3.76M | Sell |
|
|||||
|
2021
Q1 | $4.37M | Buy |
|
|||||
|
2020
Q4 | $483K | Buy |
|
|||||
|
2020
Q3 | $345K | Buy |
|
|||||
|
2020
Q2 | $240K | Buy |
|
|||||
|
2020
Q1 | $150K | Buy |
|
|||||
|
2019
Q4 | $138K | Buy |
|
|||||
|
2019
Q3 | $114K | Buy |
|
|||||
|
2019
Q2 | $97K | Buy |
|
|||||
|
2019
Q1 | $81K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $964K | Buy |
|
|||||
|
2017
Q4 | $88K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $698K | Buy |
|
|||||
|
2017
Q1 | $51K | Hold |
|
|||||
|
2016
Q4 | $62K | Hold |
|
|||||
|
2016
Q3 | $56K | Sell |
|
|||||
|
2016
Q2 | $617K | Buy |
|